[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志, 2019, 35(1):38-44.
[2] Stravitz RT, Lee WM. Seminar: Acute liver failure[J]. Lancet, 2019, 394:869-881.
[3] Kamimura H, Setsu T, Kimura N, et al. Analysis of drug-induced liver-related adverse event trend reporting between 1997 and 2019[J]. Hepatol Res, 2023,53:556-568.
[4] Rao A, Rule JA, Hameed B, et al. Secular trends in severe idiosyncratic drug-induced liver injury in North America: An update from the Acute Liver Failure Study Group Registry[J]. Am J Gastroenterol, 2022,117: 617-626.
[5] Squires JE, Rudnick DA, Hardison RM, et al. Liver transplant listing in pediatric acute liver failure: practices and participant characteristics[J]. Hepatology, 2018, 68:2338-2347.
[6] Lefkowitch JH. The pathology of acute liver failure. Adv Anat Pathol, 2016, 23:144-158.
[7] Lisman T, Luyendyk JP. Platelets as modulators of liver diseases[J]. Semin Thromb Hemost, 2018, 44:114-125.
[8] Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death[J]. Cell Death Differ, 2018, 25:486-541.
[9] Dara L, Johnson H, Suda J, et al. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis[J]. Hepatology, 2015, 62:1847-1857.
[10] Singanayagam A, Triantafyllou E. Macrophages in chronic liver failure: Diversity, plasticity and therapeutic targeting[J]. Front Immunol, 2021, 12:661182.
[11] Chauhan A, Sheriff L, Hussain MT, et al. The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure[J]. Nat Commun, 2020, 11:1939.
[12] Michalopoulos GK, Bhushan B. Liver regeneration: Biological and pathological mechanisms and implications[J]. Nat Rev Gastroenterol Hepatol, 2021, 18:40-55.
[13] Koch DG, Speiser JL, Durkalski V, et al. The natural history of acute liver injury[J]. Am J Gastroenterol, 2017,112:1389-1396.
[14] Jouanguy E. Human genetic basis of fulminant viral hepatitis[J]. Human Genetics, 2020, 139:877-884
[15] Belkaya S, Michailidis E, Korol CB, et al. Inherited IL-18BP deficiency in human fulminant viral hepatitis[J]. J Exp Med, 2019, 216:1777-1790.
[16] Roberts DW, Lee WM, Hinson JA, et al. An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure[J]. Clin Gastroenterol Hepatol, 2017, 15:555-562.
[17] Rakela JL, Karvellas CJ, Koch DG, et al. Acute liver failure: biomarkers evaluated by the acute liver failure study group[J]. Clin Translat Gastroenterol, 2023,14: e00565.
[18] Reuben A, Fontana RJ, Davern T, et al. Outcomes in adults with acute liver failure (ALF) from 1998-2013: An observational cohort study[J]. Ann Intern Med, 2016,164:724-732.
[19] Kalal CR, Maiwall R, Choudhary A, et al. Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial[J]. Dig Dis, 2022, 40:607-615.
[20] Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure[J]. Gastroenterology, 2003,125:755-764.
[21] Stravitz RT, Ellerbe C, Durkalski V, et al. Bleeding complications in acute liver failure[J]. Hepatology, 2018, 67:1931-1942.
[22] Nanchal R, Subramanian R, Karvellas CJ, et al. Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: Cardiovascular, endocrine, hematologic, pulmonary, and renal considerations[J]. Crit Care Med, 2020, 48: e173-191.
[23] MacDonald AJ, Subramanian RM, Olson JC, et al. Use of the molecular adsorbent recirculating system in acute liver failure: results of a multicenter propensity score-matched study[J]. Crit Care Med, 2022,50:286-295.
[24] Stravitz RT, Fontana RJ, Karvellas C, et al. Future directions in acute liver failure[J]. Hepatology, 2023, 78:1266-1289. |
